PHK
QTTB icon

Point72 Hong Kong’s Q32 Bio QTTB Stock Holding History

Point72 Hong Kong’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-264
Closed -$17K – 2407
2021
Q4 		$17K Buy
+264
New +$25.6K ﹤0.01% 1571
2020
Q3 		– Sell
-124
Closed -$34K – 1587
2020
Q2 		$34K Buy
+124
New +$33K ﹤0.01% 807
2019
Q3 		– Sell
-18
Closed -$6K – 1392
2019
Q2 		$6K Buy
+18
New +$7.07K ﹤0.01% 913

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Point72 Hong Kong's QTTB Position: Q1 2022 in Review

Point72 Hong Kong sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 264 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in QTTB in Q2 2019 and held it in 3 quarters. The position peaked at $34K in Q2 2020. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

  • Point72 Hong Kong reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 264 Q32 Bio shares in Q1 2022, an estimated $17K.
  • Point72 Hong Kong first reported a position in Q32 Bio in Q2 2019 and held it in 3 quarters.
  • Point72 Hong Kong's Q32 Bio position peaked at $34K in Q2 2020.
  • 106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.